3-ho-pcp-drugs (also referred to as 3-Hydroxyphencyclidine) is a dissociative research chemical of the arylcyclohexylamine class. 3-Hydroxyphencyclidine is a novel dissociative compound known for its dissociation, hallucinogenic and euphoric effects. In addition to its main role as an NMDA receptor antagonist, results have also shown that this dissociative compound has significant affinity for the μ-opioid receptor.
Ensure to store in a cool, dry place for maximum shelf-life
Our 3-ho-pcp-drugs Powders are sold strictly for research purposes only, and must not be used for human consumption. Please be sure to carefully read and agree to our before purchasing this particular compound.
3-HO-PCP is sold for research purposes only and is not be utilized for any other purposes, including, but not limited to, in vivo diagnostic purposes, in foods, in drugs, in medicinal devices, and/or cosmetics for humans and/or animals.
Prior to ordering, please make certain that you are properly equipped for research chemicals and that your work area is well-ventilated.
You must be 18 or more years old to order this product.
In conclusion you contact us via with email.
-drugs Originally synthesized by chemist Wayne E. Kenney, BAY 38-7271 (KN 38-7271) is a drug which is a cannabinoid receptor agonist developed by Bayer AG. It has analgesic and neuroprotectiveeffects and is used in scientific research, with proposed uses in the treatment of traumatic brain injury.
-drugs has analgesic and neuroprotective effects and is used in scientific research, with proposed uses in the treatment of traumatic brain injury. It is a full agonist with around the same potency as CP 55,940 in animal studies, and has fairly high affinity for both CB1 and CB2 receptors, with Ki values of 2.91nM at CB1 and 4.24nM at CB2. It has been licensed to KeyNeurotek Pharmaceuticals for clinical development, and is currently in Phase II trials.But its development appears has stopped.
Buy Cannabinoid Online, Originally synthesized by chemist Wayne E. Kenney, BAY 38-7271 (KN 38-7271) is a drug which is a cannabinoid receptor agonist developed by Bayer AG. It has analgesic and neuroprotective effects and is used in scientific research, with proposed uses in the treatment of traumatic brain injury.
Buy Cannabinoid Online, Traumatic brain injury (TBI) is the most common cause of mortality and morbidity in adults under 40 years of age in industrialized countries. Worldwide the incidence is increasing, about 9.5 million people are hospitalized per year due to TBI, and the death rate is estimated to be more than one million people per year. Recently has been characterized as a structurally novel, selective and highly potent cannabinoid CB1/CB2 receptor agonist in vitro and in vivo with pronounced neuroprotective efficacy in a rat traumatic brain injury model, showing a therapeutic window of at least 5 h.